Wuxi Biologics (Cayman) Inventory

Wuxi Biologics (Cayman) (WXXWY) currently reports a inventory of $1.4B as of December 2025. That compares with $1.5B in the prior-year period — down 5.3% year over year. Use the charts on this page to explore Wuxi Biologics (Cayman)'s inventory history and peer comparisons.

Wuxi Biologics (Cayman)'s inventory decreased from $1.5B to $1.4B — a 5.3% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Wuxi Biologics (Cayman) reported $1.4B in inventory as of December 2025. That compares with $1.5B in the prior-year period — down 5.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $1.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Wuxi Biologics (Cayman), and consider following WXXWY for alerts when major investors trade the stock.

Wuxi Biologics (Cayman) is classified in the Healthcare sector. On inventory, it currently shows $1.4B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WXXWY with unrelated industries.